The effect of 2 Hz and 100 Hz electrical stimulation of acupoint on ankle sprain in rats.
The electrical stimulation of acupoint (ESA) releases several endogenous neuropeptides, which play important roles in management of pain and inflammation. ESA with low and high frequencies has been shown to release different neuropepides, suggesting its various therapeutic effects. Pain and edema are major problems for ankle sprain. However, there have been few reports on the effects of ESA for ankle sprain. We aimed to investigate that ESA can reduce pain and edema resulting from ankle sprain, and whether there is a difference in therapeutic effects between low and high frequency ESA. To induce ankle sprain in Sprague-Dawley rats, the ankle of right hindpaw was overextended in direction of simultaneous inversion and plantar flexion. Stepping force and edema in the paw of the sprained ankle were measured by electronic balance and plethysmometer, respectively. In both 2 and 100 Hz ESA groups, stepping force was increased significantly in similar degrees (p<0.05). Only 2 Hz ESA produced the significant rapid decrease in ankle edema. This study demonstrates that ESA of 2 Hz and 100 Hz shows comparable analgesic effects, but only 2 Hz ESA can facilitate the reduction of edema caused by ankle sprain.
Hahm
Tae Soo
TS
Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. tshahm@smc.samsung.co.kr
D000818:Animals; D016512:Ankle Injuries / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy*; D018771:Arthralgia / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D004487:Edema / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D015671:Electroacupuncture / Q000379:methods*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013180:Sprains and Strains / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control*; D016896:Treatment Outcome